231 related articles for article (PubMed ID: 6195516)
1. Structural requirements for drug binding to site II on human serum albumin.
Wanwimolruk S; Birkett DJ; Brooks PM
Mol Pharmacol; 1983 Nov; 24(3):458-63. PubMed ID: 6195516
[TBL] [Abstract][Full Text] [Related]
2. Cephalosporin binding sites to human serum albumin and the relation with the N-B transition of this protein.
Nerli B; García F; Ballán C; Picó G
Biochem Mol Biol Int; 1995 May; 36(1):177-84. PubMed ID: 7663413
[TBL] [Abstract][Full Text] [Related]
3. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin.
Bhattacharya AA; Grüne T; Curry S
J Mol Biol; 2000 Nov; 303(5):721-32. PubMed ID: 11061971
[TBL] [Abstract][Full Text] [Related]
4. Detergent binding as a sensor of hydrophobicity and polar interactions in the binding cavities of proteins.
Peyre V; Lair V; André V; le Maire G; Kragh-Hansen U; le Maire M; Møller JV
Langmuir; 2005 Sep; 21(19):8865-75. PubMed ID: 16142972
[TBL] [Abstract][Full Text] [Related]
5. Effects of fatty acids on two specific drug binding sites on human serum albumin.
Birkett DJ; Myers SP; Sudlow G
Mol Pharmacol; 1977 Nov; 13(6):987-92. PubMed ID: 593269
[No Abstract] [Full Text] [Related]
6. Influence of non-steroidal anti-inflammatory drugs on the binding kinetics of dansylsarcosine to human serum albumin. Stereoselectivity, steric and inductive effects.
Keita Y; Wörner W; Veile G; Woodcock BG; Fuhr U
Arzneimittelforschung; 1996 Feb; 46(2):164-8. PubMed ID: 8720306
[TBL] [Abstract][Full Text] [Related]
7. Chain length-dependent binding of fatty acid anions to human serum albumin studied by site-directed mutagenesis.
Kragh-Hansen U; Watanabe H; Nakajou K; Iwao Y; Otagiri M
J Mol Biol; 2006 Oct; 363(3):702-12. PubMed ID: 16979183
[TBL] [Abstract][Full Text] [Related]
8. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
[TBL] [Abstract][Full Text] [Related]
9. The effects of N-B transition of human serum albumin on the specific drug-binding sites.
Wanwimolruk S; Birkett DJ
Biochim Biophys Acta; 1982 Dec; 709(2):247-55. PubMed ID: 6185151
[TBL] [Abstract][Full Text] [Related]
10. The identity of the binding sites of bile salts on bovine serum albumin.
Farruggia B; Picó G
Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):234-40. PubMed ID: 8321923
[TBL] [Abstract][Full Text] [Related]
11. Structural basis of the drug-binding specificity of human serum albumin.
Ghuman J; Zunszain PA; Petitpas I; Bhattacharya AA; Otagiri M; Curry S
J Mol Biol; 2005 Oct; 353(1):38-52. PubMed ID: 16169013
[TBL] [Abstract][Full Text] [Related]
12. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
Fehske KJ; Schläfer U; Wollert U; Müller WE
Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349
[TBL] [Abstract][Full Text] [Related]
13. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
Simard JR; Zunszain PA; Hamilton JA; Curry S
J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
[TBL] [Abstract][Full Text] [Related]
14. Benoxaprofen: plasma binding and binding interactions with some drugs and endogenous compounds.
Albengres E; Urien S; Kusmierek J; Tillement JP
Eur J Rheumatol Inflamm; 1982; 5(2):87-97. PubMed ID: 6806105
[TBL] [Abstract][Full Text] [Related]
15. Surface-enhanced Raman spectroscopy study of the interaction of the antitumoral drug emodin with human serum albumin.
Fabriciova G; Sanchez-Cortes S; Garcia-Ramos JV; Miskovsky P
Biopolymers; 2004 May-Jun 5; 74(1-2):125-30. PubMed ID: 15137109
[TBL] [Abstract][Full Text] [Related]
16. Plasma protein binding of metbufen, a new non-steroid anti-inflammatory drug, in humans.
Brunner F; Zini R; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):134-9. PubMed ID: 6201451
[TBL] [Abstract][Full Text] [Related]
17. Determining molecular binding sites on human serum albumin by displacement of oleic acid.
Sarver RW; Gao H; Tian F
Anal Biochem; 2005 Dec; 347(2):297-302. PubMed ID: 16289007
[TBL] [Abstract][Full Text] [Related]
18. Albumin binding of anti-inflammatory drugs. Utility of a site-oriented versus a stoichiometric analysis.
Honoré B; Brodersen R
Mol Pharmacol; 1984 Jan; 25(1):137-50. PubMed ID: 6708930
[TBL] [Abstract][Full Text] [Related]
19. A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions.
Buttar D; Colclough N; Gerhardt S; MacFaul PA; Phillips SD; Plowright A; Whittamore P; Tam K; Maskos K; Steinbacher S; Steuber H
Bioorg Med Chem; 2010 Nov; 18(21):7486-96. PubMed ID: 20869876
[TBL] [Abstract][Full Text] [Related]
20. Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations.
Kragh-Hansen U; Brennan SO; Galliano M; Sugita O
Mol Pharmacol; 1990 Feb; 37(2):238-42. PubMed ID: 2304452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
